Risk factors of HBs Ag positive in blood donors of Hamedan, Iran
Social Determinants of Health,
Vol. 4 No. 1 (2018),
10 Khordad 2018
,
Page 44-49
https://doi.org/10.22037/sdh.v4i1.20852
Abstract
Background: Viral hepatitis B is a common community acquired infection. It damages the liver tissue and can be a risk factor for cirrhosis and liver cancer. In the present study, we investigated the major risk factors for being HBs Ag positive among blood donors of Hamedan, Iran.
Methods: A cross-sectional study was carried out in Hamedan city. All of the blood donors in Blood Transfusion Organization Center of the city were asked to fill out a questionnaire between September 2011 and February 2012. Logistic regression was used to calculate Odds Ratios (OR) for risk factors of being HBs Ag positive using IBM SPSS Statistics for Windows, Version 22.0.
Results: Among 571 participants 119 (20.8%) were HBs Ag positive. Of all patients, 158 (27.6%) were female, 506 (88.6%) were living in urban areas. Also, 375 (65.7%) were married. Among the potential risk factors of HBs Ag positivity studied, “History of Surgery” ranked first (OR=3.11 P=0.003) and “Familial History of Liver Disease” was the second significant risk factor (OR=2.90 P=0.013). Human bite, dental filling, and needle stick had odds ratios less than one. However, they were not found to be statistically significant (P>0.05).
Conclusion: Of all risk factors investigated in the present study, “History of Surgery” suggests a risk of infection transmission through surgical team. More studies on different populations are needed due to regional characteristics of hepatitis transmission
- Blood Donors
- Hepatitis B Risk Factor
- Surgery Risks
How to Cite
References
WHO Hepatitis B Factsheet [Internet]. [cited 2017 Mar 31]. Available from: http://www.who.int/mediacentre/factsheets/fs204/en/
Luvisa BK, Hassanein TI. Hepatitis B Virus Infection and Liver Decompensation. Clin Liver Dis [Internet]. 2016 Nov;20(4):681–92. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1089326116300599
Harrison TJ, Chen J-Y, Zuckerman AJ. Hepatitis B and primary liver cancer. Cancer Treat Rev [Internet]. 1986 Mar;13(1):1–16. Available from: http://linkinghub.elsevier.com/retrieve/pii/0305737286900113
Zuckerman AJ, Harrison TJ. Hepatitis B virus chronic liver disease and hepatocellular carcinoma. Postgrad Med J [Internet]. 1987;63 Suppl 2:13–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2825153
Fabrizi F, Donato F, Messa P. Association between hepatitis B virus and chronic kidney disease: a systematic review and meta-analysis. Ann Hepatol [Internet]. 2017 Jan 1;16(1):21–47. Available from: http://948.indexcopernicus.com/abstracted.php?level=5&ICID=1226813
Gonzalez SA, Perrillo RP. Hepatitis B Virus Reactivation in the Setting of Cancer Chemotherapy and Other Immunosuppressive Drug Therapy. Clin Infect Dis [Internet]. 2016 Jun 1;62(suppl 4):S306–13. Available from: https://academic.oup.com/cid/article-lookup/doi/10.1093/cid/ciw043
Tavakolpour S, Alavian SM, Sali S. Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review. Hepat Mon [Internet]. 2016 Mar 26;16(4). Available from: http://hepatmon.com/en/articles/15623.html
Hwang JP, Lok AS-F. Management of patients with hepatitis B who require immunosuppressive therapy. Nat Rev Gastroenterol Hepatol [Internet]. 2013 Nov 19;11(4):209–19. Available from: http://www.nature.com/doifinder/10.1038/nrgastro.2013.216
Gholami Parizad E, Gholami Parizad E, Khosravi A, Amraei M, Valizadeh A, Davoudian A. Comparing HBV Viral Load in Serum, Cerumen, and Saliva and Correlation With HBeAg Serum Status in Patients With Chronic Hepatitis B Infection. Hepat Mon [Internet]. 2016 May 27;16(5):e30385. Available from: http://www.hepatmon.com/?page=article&article_id=30385
Franco E. Hepatitis B: Epidemiology and prevention in developing countries. World J Hepatol [Internet]. 2012;4(3):74. Available from: http://www.wjgnet.com/1948-5182/full/v4/i3/74.htm
Cho EJ, Kim SE, Suk KT, An J, Jeong SW, Chung WJ, et al. Current status and strategies for hepatitis B control in Korea. Clin Mol Hepatol [Internet]. 2017 Sep 25;23(3):205–11. Available from: http://www.e-cmh.org/journal/view.php?doi=10.3350/cmh.2017.0104
Mahboobi N, Porter SR, Karayiannis P, Alavian S-M. Dental treatment as a risk factor for hepatitis B and C viral infection. A review of the recent literature. J Gastrointestin Liver Dis [Internet]. 2013 Mar;22(1):79–86. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23539395
Badfar G, Shohani M, Nasirkandy MP, Mansouri A, Abangah G, Rahmati S, et al. Epidemiology of hepatitis B in pregnant Iranian women: a systematic review and meta-analysis. Arch Virol [Internet]. 2017 Oct 23; Available from: http://link.springer.com/10.1007/s00705-017-3551-6
Mojtahedzadeh S, Karimi M, Jafari K, Moradi A. Prevalence of HBsAg and VDRL positive cases in Hamedan province blood donors. J Res Med Shaheed Beheshti Univ Med Sci. 1995;3(4):74.
Delage G, Infante–Rivard C, Chiavetta J, Willems B, Pi D, Fast M. Risk factors for acquisition of hepatitis C virus infection in blood donors: Results of a case-control study. Gastroenterology [Internet]. 1999 Apr;116(4):893–9. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0016508599700727
Martinson FEA, Weigle KA, Royce RA, Weber DJ, Suchindran CM, Lemon SM. Risk Factors for Horizontal Transmission of Hepatitis B Virus in a Rural District in Ghana. Am J Epidemiol [Internet]. 1998 Mar 1;147(5):478–87. Available from: https://academic.oup.com/aje/article-lookup/doi/10.1093/oxfordjournals.aje.a009474
Singh J, Gupta S, Khare S, Bhatia R, Jain DC, Sokhey J. A severe and explosive outbreak of hepatitis B in a rural population in Sirsa district, Haryana, India: unnecessary therapeutic injections were a major risk factor. Epidemiol Infect [Internet]. 2000 Dec;125(3):693–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11218219
Beier FJ. [Risk of endangering patients by hepatitis B infected surgeons: monitoring the health of medical personnel in hospitals must be evaluated]. Gesundheitswesen [Internet]. 2000 Feb;62(2):64–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10740353
Alizadeh AHM, Ranjbar M, Ansari S, MirArab A, Alavian SM, Mohammad K, et al. Seroprevalence of hepatitis B in Nahavand, Islamic Republic of Iran. East Mediterr Health J [Internet]. 2006 Sep;12(5):528–37. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17333790
Saboori Ghanad M, Ghasemi G. Frequency distribution of HBsAg in Hamedan province blood donors , Feb to Dec 1995. J Hamedan Univ Med Sci Heal Serv. 1997;4(2).
Gambhir R, Kapoor V, Setia S. Hepatitis B and C infection: Clinical implications in dental practice. Eur J Gen Dent [Internet]. 2013;2(1):13. Available from: http://www.ejgd.org/text.asp?2013/2/1/13/106795
- Abstract Viewed: 274 times
- PDF Downloaded: 112 times